{
  "nctId": "NCT02728726",
  "briefTitle": "Sugammadex vs Placebo to Prevent Residual Neuromuscular Block",
  "officialTitle": "Randomized Double---Blinded, Controlled Trial to Compare the Effectiveness of Sugammadex vs. Placebo to Prevent Residual Neuromuscular Block in the Post---Anesthesia Care Unit as Evaluated With a Non---Invasive Respiratory Volume Monitor",
  "protocolDocument": {
    "nctId": "NCT02728726",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2017-06-29",
    "uploadDate": "2022-05-10T15:12",
    "size": 2576452,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02728726/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "PHASE4"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "QUADRUPLE",
  "enrollmentInfo": {
    "enrollmentCount": 260,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2016-06",
    "completionDate": "2019-12",
    "primaryCompletionDate": "2019-12",
    "firstSubmitDate": "2016-03-15",
    "firstPostDate": "2016-04-05"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Patients undergoing surgery with general anesthesia\n* Patients weighing \\> or = 80 pounds\n* Patients not intubated prior to surgery\n* Patients who are able to give informed consent\n\nExclusion Criteria:\n\n* Patients unable to give informed consent.\n* Patients whose condition will not allow for placement of the electrode PadSet of ExSpiron\n* Patients who are anticipated to remain intubated in recovery period.",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "maximumAge": "100 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Decreased Minute Ventilation (MV)",
        "description": "The number of subjects who have a MV as defined as \\[MV \\<80% MV predicted (MVPRED) based on Body Surface Area\\]. MV (or respiratory minute volume or minute volume) is the volume of gas inhaled (inhaled minute volume) or exhaled (exhaled minute volume) from a person's lungs per minute.",
        "timeFrame": "15---30 minutes after Post-anesthesia care unit (PACU) arrival"
      },
      {
        "measure": "Decreased Average Minute Ventilation (MV)",
        "description": "The number of subjects who have an average MV \\<80% MV predicted (MVPRED) based on Body Surface Area. MV (or respiratory minute volume or minute volume) is the volume of gas inhaled (inhaled minute volume) or exhaled (exhaled minute volume) from a person's lungs per minute.",
        "timeFrame": "15---30 minutes after Post-anesthesia care unit (PACU) arrival"
      }
    ],
    "secondary": [
      {
        "measure": "Train of Four (TOF) Ratio",
        "description": "The number of subjects to have a normal TOF ratio (\\>0.90) indicative of full neuromuscular recovery in the Post-anesthesia care unit (PACU)",
        "timeFrame": "upon PACU discharge, approximately 8 hours"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 2,
      "secondaryCount": 1,
      "otherCount": 0,
      "totalCount": 3
    },
    "studyDesign": {
      "phases": [
        "PHASE4"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 54,
    "complexityCategory": "Complex"
  },
  "collectionDate": "2025-09-22T02:29:19.425Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}